Clinical trial NCT01831440 - References

Depressive Disorder — Pharmacotherapy and Psychotherapy for MDD After Remission on Psychology and Neuroimaging

Citation(s)

•   Kuehner C
  An evaluation of the 'Coping with Depression Course' for relapse prevention with unipolar depressed patients. Psychother Psychosom. 2005;74(4):254-9.
•   Mattisson C, Bogren M, Horstmann V, Munk-Jörgensen P, Nettelbladt P
  The long-term course of depressive disorders in the Lundby Study. Psychol Med. 2007 Jun;37(6):883-91. Epub 2007 Feb 19.
•   Paykel ES, Scott J, Teasdale JD, Johnson AL, Garland A, Moore R, Jenaway A, Cornwall PL, Hayhurst H, Abbott R, Pope M
  Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch Gen Psychiatry. 1999 Sep;56(9):829-35.
•   Petersen TJ
  Enhancing the efficacy of antidepressants with psychotherapy. J Psychopharmacol. 2006 May;20(3 Suppl):19-28. Review.
•   Scott J, Teasdale JD, Paykel ES, Johnson AL, Abbott R, Hayhurst H, Moore R, Garland A
  Effects of cognitive therapy on psychological symptoms and social functioning in residual depression. Br J Psychiatry. 2000 Nov;177:440-6.
•   Vitiello B
  Combined cognitive-behavioural therapy and pharmacotherapy for adolescent depression: Does it improve outcomes compared with monotherapy? CNS Drugs. 2009;23(4):271-80.
•   Watkins E, Scott J, Wingrove J, Rimes K, Bathurst N, Steiner H, Kennell-Webb S, Moulds M, Malliaris Y
  Rumination-focused cognitive behaviour therapy for residual depression: a case series. Behav Res Ther. 2007 Sep;45(9):2144-54. Epub 2007 Mar 26.

The Influence of Pharmacotherapy and Psychotherapy for MDD After Remission on Psychology and Neuroimaging：A Comparative Longitudinal Study

Details for clinical trial NCT01831440